Clinical trial Recruiting at 1 site Phase 3 Interventional Ages 1 Day to 31 Days

Using nitric oxide during heart surgery in newborns to prevent kidney injury

Official title: Efficacy of Nitric Oxide Administration During Cardiopulmonary Bypass in Neonates at Reducing the Risk of Acute Kidney Injury

Run by Children's Hospital Medical Center, Cincinnati · NCT04216927 · Data updated 2026-11-12

This study is testing if using nitric oxide during heart surgery can help newborns avoid kidney injury after their operation.

More Bariatric Surgery trials

Quick facts

PhasePhase 3
Study typeInterventional
Ages1 Day to 31 Days
SexAll
Enrollment40 (estimated)
SponsorChildren's Hospital Medical Center, Cincinnati
Academic / other
Locations1 site (Cincinnati, Ohio)
StatusRecruiting
StartedJanuary 10, 2023
Main results expectedJune 30, 2027
Study endsJune 30, 2027
Registry record updatedAugust 5, 2026
Trial IDNCT04216927 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates for this study are neonates aged 31 days or younger who are scheduled for cardiac surgery involving cardiopulmonary bypass.

Probably not a fit

Patients with pre-existing kidney issues, major congenital anomalies, or those requiring emergency surgery may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This clinical trial investigates the use of nitric oxide during cardiopulmonary bypass in neonates undergoing cardiac surgery for congenital heart disease. The study aims to determine if administering nitric oxide can reduce the incidence of acute kidney injury, a common complication affecting up to 60% of high-risk patients post-surgery. By targeting the inflammatory and coagulation pathways, the researchers hope to improve renal outcomes in this vulnerable population. The trial is interventional and is currently in Phase 3.

Why it matters

Potential benefit: If successful, this approach could significantly reduce the risk of acute kidney injury in neonates undergoing cardiac surgery.

How similar studies have gone: While the use of nitric oxide in similar contexts has shown promise, this specific approach in neonates undergoing cardiac surgery is novel and has not been widely tested.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* All neonates (≤31 days) undergoing cardiac surgery with CPB for CHD will be deemed eligible for enrollment.

Exclusion Criteria:

1. Failure to obtain informed consent from parent/guardian
2. Clinical signs of preoperative persistent elevated pulmonary vascular resistance,
3. Emergency surgery,
4. Episode of cardiac arrest within 1 week before surgery,
5. Recent treatment with steroids and/or a condition that may require treatment with steroids (excluding steroid administration specifically for CPB),
6. Use of inhaled NO (iNO) immediately prior to surgery,
7. Structural renal abnormalities by ultrasound,
8. Preoperative AKI,
9. Use of other investigational drugs,
10. Weight less than \<2 kg,
11. Gestational age \<36 weeks,
12. Major extracardiac congenital anomalies,
13. Non-English speakers.

Where it's running

  • Cincinnati Children's Hospital Medical Center
    Cincinnati, Ohio, United States
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.